Diffuse pulmonary meningotheliomatosis with pan-TRK expression by immunohistochemistry: a novel finding and potential

Cansu Karakas1, Michael A Nead2, Moises J Velez3

  • 1Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Diagnostic Pathology
|February 14, 2023
PubMed
Abstract

Insights

Diffuse pulmonary meningotheliomatosis (DPM) is rare, often asymptomatic lung condition. This case highlights pan-TRK expression in pulmonary meningothelial-like nodules (PMNs), aiding diagnosis and avoiding errors.

Area of Science:

  • Pulmonology
  • Pathology
  • Oncology

Background:

  • Pulmonary meningothelial-like nodules (PMNs) are benign lung lesions of uncertain clinical significance.
  • Diffuse pulmonary meningotheliomatosis (DPM) presents as widespread PMNs and is infrequently documented.
  • DPM is associated with various neoplastic and non-neoplastic lung conditions.

Approach:

  • A case study of a 59-year-old female patient with cough and bilateral pulmonary nodules.
  • Diagnostic methods included CT imaging, transbronchial biopsies, and immunohistochemical staining.
  • RNA-based next-generation sequencing was performed to detect NTRK fusions.

Key Points:

  • Histopathology revealed nodular interstitial proliferations with epithelioid to spindled cells.
  • Immunohistochemistry showed diffuse positivity for EMA and progesterone receptor.
  • Significant finding: pan-TRK exhibited strong, diffuse membranous expression in lesional cells, while INSM1 was negative.
  • NTRK gene rearrangements were absent.

Conclusions:

  • This report details a rare case of DPM with previously undescribed pan-TRK expression in PMNs.
  • The findings offer insights into the potential physiologic nature of PMNs.
  • Emphasizes recognizing pan-TRK immunoexpression to prevent diagnostic misinterpretations.

Related Concept Videos